Nuzenio

Raymond James Maintains

Raymond James Maintains news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 14 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Raymond James Maintains Grindr(GRND.US) With Buy Rating, Raises Target Price to $22 - MoomooMoomoo · Sat, 08 Aug 2026 11:15:00 GMTRaymond James Adjusts CDW Price Target to $155 From $150, Maintains Strong Buy Rating - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 15:56:06 GMTRaymond James Adjusts PT on SBA Communications to $264 From $270, Maintains Strong Buy Rating - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 10:37:10 GMTALNY Upgraded by Raymond James -- Maintains Price Target at $420 - GuruFocusGuruFocus · Mon, 03 Aug 2026 23:24:02 GMTRaymond James Adjusts PT on Church & Dwight to $112 From $110, Maintains Outperform Rating - marketscreener.commarketscreener.com · Mon, 03 Aug 2026 10:32:55 GMTRaymond James Maintains Phathom Pharmaceuticals(PHAT.US) With Buy Rating, Cuts Target Price to $21 - MoomooMoomoo · Fri, 31 Jul 2026 13:36:00 GMTRaymond James Adjusts Price Target on Mastercard to $632 From $609, Maintains Outperform Rating - marketscreener.commarketscreener.com · Fri, 31 Jul 2026 09:48:21 GMTRaymond James Adjusts Price Target on DexCom to $94 From $91, Maintains Strong Buy Rating - MoomooMoomoo · Fri, 31 Jul 2026 07:00:00 GMT

Timeline

Sat, 08 Aug 2026 11:15:00 GMTRaymond James Maintains Grindr(GRND.US) With Buy Rating, Raises Target Price to $22 - Moomoo
Wed, 05 Aug 2026 15:56:06 GMTRaymond James Adjusts CDW Price Target to $155 From $150, Maintains Strong Buy Rating - Yahoo Finance
Tue, 04 Aug 2026 10:37:10 GMTRaymond James Adjusts PT on SBA Communications to $264 From $270, Maintains Strong Buy Rating - Yahoo Finance
Mon, 03 Aug 2026 23:24:02 GMTALNY Upgraded by Raymond James -- Maintains Price Target at $420 - GuruFocus
Mon, 03 Aug 2026 10:32:55 GMTRaymond James Adjusts PT on Church & Dwight to $112 From $110, Maintains Outperform Rating - marketscreener.com
Fri, 31 Jul 2026 13:36:00 GMTRaymond James Maintains Phathom Pharmaceuticals(PHAT.US) With Buy Rating, Cuts Target Price to $21 - Moomoo

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Raymond James Maintains.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.